CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | 4-hydroxynon-2-enal |
|
Accession: | CHEBI:32585
|
browse the term
|
Definition: | An enal consisting of non-2-ene having an oxo group at the 1-position and a hydroxy group at the 4-position. |
Synonyms: | related_synonym: | 4-HNE; 4-Hydroxy-2,3-nonenal; 4-Hydroxy-2-nonenal; 4-Hydroxynonenal; Formula=C9H16O2; HNE; InChI=1S/C9H16O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-9,11H,2-4,6H2,1H3; InChIKey=JVJFIQYAHPMBBX-UHFFFAOYSA-N; SMILES=[H]C(=CC=O)C(O)CCCCC |
| xref: | CAS:29343-52-0; LINCS:LSM-4344 |
| xref_mesh: | MESH:C027576 |
| xref: | Wikipedia:4-Hydroxynonenal |
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ABCA1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects binding increases expression multiple interactions |
ISO |
4-hydroxy-2-nonenal binds to ABCC1 protein 4-hydroxy-2-nonenal results in increased expression of ABCC1 mRNA [GSTM1 protein co-treated with ABCC1 protein] results in increased susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:15672542 PMID:19191707 PMID:21925487 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects export multiple interactions |
EXP ISO |
ABCC2 protein affects the export of 4-hydroxy-2-nonenal metabolite 4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Ascorbic Acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]] |
CTD |
PMID:12623073 PMID:19326901 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
affects binding |
EXP |
4-hydroxy-2-nonenal binds to ACTA1 protein |
CTD |
PMID:15886073 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Actb |
actin, beta |
affects binding |
ISO |
ACTB protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn1 |
actinin, alpha 1 |
affects binding |
ISO |
ACTN1 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Actn4 |
actinin alpha 4 |
affects binding |
ISO |
ACTN4 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ADH7 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adi1 |
acireductone dioxygenase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ADI1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:45,306,885...45,313,847
Ensembl chr 6:45,306,841...45,313,842
|
|
G |
Adora1 |
adenosine A1 receptor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ADORA1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adora2b |
adenosine A2B receptor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ADORA2B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ADRB2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Ago2 |
argonaute RISC catalytic component 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AGO2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
|
|
G |
Ago3 |
argonaute RISC catalytic component 3 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AGO3 mRNA 4-hydroxy-2-nonenal results in increased expression of AGO3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:138,632,367...138,714,230
Ensembl chr 5:138,639,569...138,714,230
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AGRN mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
|
|
G |
Agt |
angiotensinogen |
affects binding multiple interactions |
ISO |
4-hydroxy-2-nonenal binds to AGT protein modified form; AGT protein modified form binds to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal binds to and results in increased lipidation of AGT protein modified form; [AGT protein modified form results in increased chemical synthesis of Lipid Peroxides] which results in increased abundance of 4-hydroxy-2-nonenal; [Ascorbic Acid co-treated with Copper Sulfate] promotes the reaction [AGT protein modified form results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]]; AGT protein modified form results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]; Losartan inhibits the reaction [[AGT protein modified form co-treated with Ascorbic Acid co-treated with Copper Sulfate] results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]] |
CTD |
PMID:20977208 PMID:26111765 PMID:31144504 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahsa2 |
activator of HSP90 ATPase homolog 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of AHSA2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:97,476,304...97,485,725
Ensembl chr14:97,476,817...97,485,657
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of AIFM1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akna |
AT-hook transcription factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AKNA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases reduction increases expression |
ISO |
AKR1A1 protein results in increased reduction of 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of AKR1A1 mRNA |
CTD |
PMID:10510318 PMID:19191707 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
affects reduction increases reduction |
ISO |
AKR1B1 protein affects the reduction of 4-hydroxy-2-nonenal AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal; AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal metabolite |
CTD |
PMID:9890881 PMID:10510318 PMID:11306073 PMID:21329684 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases reduction multiple interactions increases metabolic processing |
ISO |
AKR1B10 protein results in increased reduction of 4-hydroxy-2-nonenal Oleanolic Acid inhibits the reaction [AKR1B10 protein results in increased metabolism of 4-hydroxy-2-nonenal] |
CTD |
PMID:19013440 PMID:21329684 PMID:27417252 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression increases response to substance multiple interactions |
ISO |
4-hydroxy-2-nonenal results in increased expression of AKR1C3 mRNA; 4-hydroxy-2-nonenal results in increased expression of AKR1C3 protein AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal 7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal] |
CTD |
PMID:22964423 PMID:30849339 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
decreases response to substance affects response to substance increases response to substance multiple interactions increases expression |
ISO |
AKR7A2 protein results in decreased susceptibility to 4-hydroxy-2-nonenal AKR7A2 protein affects the susceptibility to 4-hydroxy-2-nonenal AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal 7-hydroxycoumarin affects the reaction [AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal]; AKR7A2 protein affects the reaction [NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal] 4-hydroxy-2-nonenal results in increased expression of AKR7A2 mRNA; 4-hydroxy-2-nonenal results in increased expression of AKR7A2 protein |
CTD |
PMID:22001351 PMID:22964423 PMID:30849339 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
affects response to substance multiple interactions increases activity decreases phosphorylation |
EXP ISO |
AKT1 protein affects the susceptibility to 4-hydroxy-2-nonenal AKT1 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2 protein] 4-hydroxy-2-nonenal results in increased activity of AKT1 protein 4-hydroxy-2-nonenal results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:18805481 PMID:23845594 PMID:24825450 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of RB1 protein modified form; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of TNF protein; [ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein]; sulforaphane inhibits the reaction [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] |
CTD |
PMID:33007382 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases metabolic processing multiple interactions increases oxidation |
ISO |
ALDH1A1 protein results in increased metabolism of 4-hydroxy-2-nonenal [APC protein mutant form results in increased expression of ALDH1A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal ALDH1A1 protein results in increased oxidation of 4-hydroxy-2-nonenal |
CTD |
PMID:21256123 PMID:21967605 PMID:22339434 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
multiple interactions increases oxidation |
ISO |
[APC protein mutant form results in increased expression of ALDH2 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal ALDH2 protein results in increased oxidation of 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal binds to and results in decreased activity of ALDH2 protein; ALDH2 protein inhibits the reaction [Rotenone results in increased abundance of 4-hydroxy-2-nonenal] |
CTD |
PMID:21967605 PMID:22339434 PMID:25263579 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
decreases response to substance affects metabolic processing affects response to substance increases metabolic processing multiple interactions increases oxidation |
ISO EXP |
ALDH3A1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal ALDH3A1 protein affects the metabolism of 4-hydroxy-2-nonenal ALDH3A1 protein affects the susceptibility to 4-hydroxy-2-nonenal ALDH3A1 protein results in increased metabolism of 4-hydroxy-2-nonenal [APC protein mutant form results in increased expression of ALDH3A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal ALDH3A1 protein results in increased oxidation of 4-hydroxy-2-nonenal |
CTD |
PMID:11018474 PMID:11306050 PMID:15905174 PMID:21256123 PMID:21967605 PMID:22339434 More...
|
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
affects binding decreases response to substance |
ISO |
4-hydroxy-2-nonenal binds to ALDH3B1 protein ALDH3B1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:20699116 |
|
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ALDH6A1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
increases metabolic processing decreases response to substance |
ISO |
ALDH7A1 protein results in increased metabolism of 4-hydroxy-2-nonenal ALDH7A1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:21338592 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
affects binding |
ISO |
ALDOA protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
multiple interactions |
ISO |
Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to ALDOA protein] |
CTD |
PMID:20889679 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
multiple interactions |
ISO |
ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein] |
CTD |
PMID:19837106 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ALOX5AP mRNA |
CTD |
PMID:19191707 |
|
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Alpk1 |
alpha-kinase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ALPK1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157
|
|
G |
Als2 |
alsin Rho guanine nucleotide exchange factor ALS2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ALS2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737
|
|
G |
Amph |
amphiphysin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AMPH mRNA |
CTD |
PMID:12419474 |
|
NCBI chr17:45,739,385...45,982,905
Ensembl chr17:45,739,395...45,983,315
|
|
G |
Anln |
anillin, actin binding protein |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ANLN mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ANP32A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Aoah |
acyloxyacyl hydrolase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AOAH mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of AOX1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap1s3 |
adaptor related protein complex 1 subunit sigma 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AP1S3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:80,950,402...81,009,889
Ensembl chr 9:80,950,715...81,009,798
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
decreases expression multiple interactions affects response to substance affects oxidation |
ISO |
4-hydroxy-2-nonenal results in decreased expression of APC mRNA [APC protein affects the oxidation of 4-hydroxy-2-nonenal] which affects the abundance of 4-hydroxynonenoic acid; [APC protein mutant form results in increased expression of ALDH1A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of ALDH2 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of ALDH3A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of GSTA4 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of SLC7A11 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal APC protein affects the susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:12419474 PMID:21967605 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of APEX1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apoa1 |
apolipoprotein A1 |
affects binding |
ISO |
4-hydroxy-2-nonenal binds to APOA1 protein |
CTD |
PMID:18778096 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apod |
apolipoprotein D |
decreases abundance |
ISO |
APOD protein results in decreased abundance of 4-hydroxy-2-nonenal |
CTD |
PMID:28182653 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
App |
amyloid beta precursor protein |
decreases expression multiple interactions |
ISO |
4-hydroxy-2-nonenal results in decreased expression of APP mRNA [[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal; [APP protein modified form inhibits the reaction [[Copper co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide]] which results in increased chemical synthesis of 4-hydroxy-2-nonenal; Deferoxamine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; Edetic Acid inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; Trientine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal] |
CTD |
PMID:12419474 PMID:17964426 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ARHGAP11A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
|
|
G |
Arhgap22 |
Rho GTPase activating protein 22 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ARHGAP22 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548
|
|
G |
Arhgap27 |
Rho GTPase activating protein 27 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ARHGAP27 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:88,280,470...88,313,225
Ensembl chr10:88,280,455...88,313,185
|
|
G |
Arhgap5 |
Rho GTPase activating protein 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ARHGAP5 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arhgef3 |
Rho guanine nucleotide exchange factor 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ARHGEF3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945
|
|
G |
Arid5a |
AT-rich interaction domain 5A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ARID5A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ARRDC3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ASF1B mRNA 4-hydroxy-2-nonenal results in increased expression of ASF1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Aspm |
assembly factor for spindle microtubules |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ASPM mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Atad5 |
ATPase family, AAA domain containing 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ATAD5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:65,070,682...65,118,489
Ensembl chr10:65,070,689...65,117,845
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ATF3 protein |
CTD |
PMID:19041636 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression multiple interactions |
EXP |
4-hydroxy-2-nonenal results in increased expression of ATF4 mRNA; 4-hydroxy-2-nonenal results in increased expression of ATF4 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF4 protein] |
CTD |
PMID:24291486 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression multiple interactions |
EXP |
4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form] |
CTD |
PMID:24291486 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ATG5 mRNA |
CTD |
PMID:35550146 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ATG7 mRNA |
CTD |
PMID:35550146 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atm |
ATM serine/threonine kinase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ATM mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1b3 |
ATPase Na+/K+ transporting subunit beta 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ATP1B3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
affects binding |
ISO |
4-hydroxy-2-nonenal binds to ATP5F1A protein |
CTD |
PMID:19374891 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ATP6V1A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
Atr |
ATR serine/threonine kinase |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ATR mRNA 4-hydroxy-2-nonenal results in increased expression of ATR mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Avil |
advillin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AVIL mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
|
|
G |
B2m |
beta-2 microglobulin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of B2M mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BABAM2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BAD mRNA 4-hydroxy-2-nonenal results in increased expression of BAD protein |
CTD |
PMID:12419474 PMID:24825450 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Batf2 |
basic leucine zipper ATF-like transcription factor 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BATF2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression increases expression |
ISO EXP |
4-hydroxy-2-nonenal results in decreased expression of BAX mRNA 4-hydroxy-2-nonenal results in increased expression of BAX protein |
CTD |
PMID:12419474 PMID:15607904 PMID:21187080 PMID:24825450 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
multiple interactions increases expression |
EXP |
4-phenylbutylamine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of BBC3 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of BBC3 mRNA] |
CTD |
PMID:24291486 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bbx |
BBX high mobility group box domain containing |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BBX mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcar3 |
BCAR3 adaptor protein, NSP family member |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BCAR3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BCL2A1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BCL2L11 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BCL3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BCL6 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases expression multiple interactions |
EXP |
4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA CREBBP protein inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA] |
CTD |
PMID:16337876 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bgn |
biglycan |
multiple interactions |
ISO |
[[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of 4-hydroxy-2-nonenal |
CTD |
PMID:35234341 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BHLHE41 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BID mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression decreases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BIRC5 mRNA 4-hydroxy-2-nonenal results in decreased expression of BIRC5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blm |
BLM RecQ like helicase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BLM mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BLVRB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmp1 |
bone morphogenetic protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BMP1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BNIP3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BRAF mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BUB1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of BUB1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of BZW1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
|
|
G |
C5ar1 |
complement C5a receptor 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of C5AR1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:76,948,622...76,959,826
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CACNA1A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cadps |
calcium dependent secretion activator |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CADPS mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:12,289,803...12,742,786
Ensembl chr15:12,290,262...12,742,779
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
increases secretion |
EXP |
4-hydroxy-2-nonenal results in increased secretion of CALCA protein |
CTD |
PMID:17684094 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Calcoco1 |
calcium binding and coiled coil domain 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CALCOCO1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:133,834,705...133,849,515
Ensembl chr 7:133,834,707...133,849,422
|
|
G |
Calr3 |
calreticulin 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CALR3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
|
|
G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CAMK1D mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
affects binding |
ISO |
CAP1 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
|
|
G |
Capn2 |
calpain 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CAPN2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Capns1 |
calpain, small subunit 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CAPNS1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
affects binding |
ISO |
CAPZB protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Car12 |
carbonic anhydrase 12 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CAR12 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car2 |
carbonic anhydrase 2 |
affects binding |
ISO |
CA2 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Carhsp1 |
calcium regulated heat stable protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CARHSP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
|
|
G |
Cask |
calcium/calmodulin dependent serine protein kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CASK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
|
|
G |
Casp1 |
caspase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CASP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage |
ISO EXP |
4-hydroxy-2-nonenal results in increased cleavage of and results in increased activity of CASP3 protein; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein] Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein] 4-hydroxy-2-nonenal results in increased cleavage of CASP3 protein |
CTD |
PMID:11488593 PMID:16322078 PMID:16337876 PMID:17263905 PMID:19326901 PMID:20114059 PMID:21187080 PMID:24291486 PMID:24825450 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CASP4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CASP7 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CASP8 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal results in increased activity of CASP9 protein pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] |
CTD |
PMID:16322078 PMID:17263905 PMID:21187080 PMID:24825450 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CAT mRNA |
CTD |
PMID:19191707 PMID:24423726 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cblb |
Cbl proto-oncogene B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CBLB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCL17 mRNA 4-hydroxy-2-nonenal results in increased expression of CCL17 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCL2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCL22 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCL3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCL4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions decreases expression |
ISO |
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] 4-hydroxy-2-nonenal results in decreased expression of CCL5 mRNA |
CTD |
PMID:19191707 PMID:19627980 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCL7 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCL6 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCNA2 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCNB1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of CCND1] 4-hydroxy-2-nonenal results in increased expression of CCND1; 4-hydroxy-2-nonenal results in increased expression of CCND1 mRNA |
CTD |
PMID:16328008 PMID:19191707 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCND2 protein |
CTD |
PMID:15607904 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions |
ISO |
[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein] |
CTD |
PMID:33007382 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCNF mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CCNG1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCNG2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccnk |
cyclin K |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCNK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 6:127,090,115...127,113,195
Ensembl chr 6:127,090,569...127,113,191
|
|
G |
Ccnt1 |
cyclin T1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCNT1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CCR1 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Cd14 |
CD14 molecule |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CD14 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd300a |
Cd300a molecule |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CD300A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:99,929,801...99,942,674
Ensembl chr10:99,929,801...99,942,674
|
|
G |
Cd300lb |
CD300 molecule-like family member b |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CD300LB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790
|
|
G |
Cd300lf |
Cd300 molecule-like family member F |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CD300LF mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:100,359,942...100,376,130
Ensembl chr10:100,359,943...100,376,041
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CD36 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd40 |
CD40 molecule |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CD40 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd44 |
CD44 molecule |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CD44 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd47 |
Cd47 molecule |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CD47 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd83 |
CD83 molecule |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CD83 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CD86 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDC20 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDC25A mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDC25C mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdca2 |
cell division cycle associated 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDCA2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in decreased expression of CDH1 protein |
CTD |
PMID:34503147 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDH2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh3 |
cadherin 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDH3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
4-hydroxy-2-nonenal binds to and results in increased alkylation of and results in decreased activity of CDK2 protein |
CTD |
PMID:26910110 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
increases expression multiple interactions |
ISO |
4-hydroxy-2-nonenal results in increased expression of CDK6 mRNA [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein] |
CTD |
PMID:19191707 PMID:33007382 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdk9 |
cyclin-dependent kinase 9 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDK9 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CDKN1A protein |
CTD |
PMID:15607904 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDKN1C mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CDKN2D mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CEBPA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CENPA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cep290 |
centrosomal protein 290 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CEP290 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases activity |
ISO |
4-hydroxy-2-nonenal results in decreased activity of CES1 protein |
CTD |
PMID:21878322 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces2h |
carboxylesterase 2H |
increases activity |
ISO |
4-hydroxy-2-nonenal results in increased activity of CES2 protein |
CTD |
PMID:21878322 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cfb |
complement factor B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CFB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfl1 |
cofilin 1 |
affects binding |
ISO |
CFL1 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CHEK1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chml |
CHM like Rab escort protein |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CHML mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:87,609,647...87,619,868
Ensembl chr13:87,589,298...87,619,862
|
|
G |
Cilk1 |
ciliogenesis associated kinase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CILK1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CISH mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CKS1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CKS2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Cldn11 |
claudin 11 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CLDN11 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CLEC12A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Clec4a |
C-type lectin domain family 4, member A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CLEC4N mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:156,340,439...156,434,212
Ensembl chr 4:156,414,688...156,432,402
|
|
G |
Clec4d |
C-type lectin domain family 4, member D |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CLEC4D mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
|
|
G |
Clec5a |
C-type lectin domain containing 5A |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CLEC5A mRNA 4-hydroxy-2-nonenal results in increased expression of CLEC5A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:69,407,125...69,416,872
Ensembl chr 4:69,407,835...69,416,859
|
|
G |
Clk3 |
CDC-like kinase 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CLK3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of COL1A1 mRNA; 4-hydroxy-2-nonenal results in increased expression of COL1A1 protein |
CTD |
PMID:14672615 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of COMT mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cp |
ceruloplasmin |
decreases expression affects abundance |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CP mRNA CP protein affects the abundance of 4-hydroxy-2-nonenal |
CTD |
PMID:12572680 PMID:19191707 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpe |
carboxypeptidase E |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CPE mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases expression increases phosphorylation |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CREB1 mRNA 4-hydroxy-2-nonenal results in increased phosphorylation of CREB1 protein |
CTD |
PMID:12419474 PMID:16337876 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
EXP |
CREBBP protein inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA] |
CTD |
PMID:16337876 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CREG1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
|
|
G |
Crot |
carnitine O-octanoyltransferase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CROT mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CRY1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CRY2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Cryz |
crystallin zeta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CRYZ mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CSF1R mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CSF2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CSF3 mRNA 4-hydroxy-2-nonenal results in increased expression of CSF3 mRNA; 4-hydroxy-2-nonenal results in increased expression of CSF3 protein |
CTD |
PMID:19191707 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Csnk1g2 |
casein kinase 1, gamma 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CSNK1G2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:9,076,739...9,095,082
Ensembl chr 7:9,076,740...9,095,052
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of AXUD1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CTNNB1 mRNA; 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 protein |
CTD |
PMID:12419474 PMID:24825450 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsd |
cathepsin D |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of CTSD mRNA]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of CTSD mRNA] |
CTD |
PMID:35550146 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsl |
cathepsin L |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CTSL mRNA |
CTD |
PMID:12419474 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Cttn |
cortactin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CTTN mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
|
|
G |
Cux1 |
cut-like homeobox 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CUX1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein] |
CTD |
PMID:19627980 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CXCL14 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CXCL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of CXCR4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases abundance |
ISO |
CYBB protein results in increased abundance of 4-hydroxy-2-nonenal |
CTD |
PMID:19417757 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal affects the localization of CYCS protein pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal affects the localization of CYCS protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal affects the localization of CYCS protein] |
CTD |
PMID:16322078 PMID:17263905 PMID:21187080 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[CYP1A2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP1A2 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal |
CTD |
PMID:21766881 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[CYP2B6 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid; [CYP2B6 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP2B6 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal |
CTD |
PMID:21766881 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions |
ISO |
[CYP2C29 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid; [CYP2C29 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP2C29 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal |
CTD |
PMID:21766881 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
multiple interactions |
ISO |
[CYP2J2 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid; [CYP2J2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP2J2 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal |
CTD |
PMID:21766881 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[[CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; [CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal; [CYP3A4 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid |
CTD |
PMID:21766881 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CYSLTR1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
|
|
G |
Cyth4 |
cytohesin 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of CYTH4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
|
|
G |
Dap |
death-associated protein |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of DAP mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DAPK1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dbf4 |
DBF4-CDC7 kinase regulatory subunit |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DBF4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
|
|
G |
Dcn |
decorin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DCN mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
EXP |
4-hydroxy-2-nonenal results in increased expression of DDIT3 mRNA; 4-hydroxy-2-nonenal results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of DDIT3 mRNA] |
CTD |
PMID:24291486 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DDIT4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DDR2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Denr |
density regulated reinitiation and release factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DENR mRNA |
CTD |
PMID:19191707 |
|
NCBI chr12:32,662,512...32,685,283
Ensembl chr12:32,662,516...32,683,843
|
|
G |
Dffa |
DNA fragmentation factor subunit alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DFFA mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DFFB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dgkh |
diacylglycerol kinase, eta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DGKH mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:53,981,079...54,150,470
Ensembl chr15:53,991,481...54,150,706
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DHX58 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DIO2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DLGAP5 mRNA 4-hydroxy-2-nonenal results in increased expression of DLGAP5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of DNAJB4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DNAJC3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dnase2 |
deoxyribonuclease 2, lysosomal |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of DNASE2A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DNPH1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
affects binding |
ISO |
4-hydroxy-2-nonenal binds to DPYSL2 protein |
CTD |
PMID:19374891 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Drd2 |
dopamine receptor D2 |
decreases expression |
EXP |
4-hydroxy-2-nonenal results in decreased expression of DRD2 protein |
CTD |
PMID:20570720 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Dst |
dystonin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of DST mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
affects binding |
ISO |
DYNLT3 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of E2F1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of E2F2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of E2F8 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ECHDC3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Edn1 |
endothelin 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EDN1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
decreases expression |
EXP |
4-hydroxy-2-nonenal results in decreased expression of EEF2 protein |
CTD |
PMID:16469450 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Efna4 |
ephrin A4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EFNA4 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:174,748,729...174,752,979
Ensembl chr 2:174,748,724...174,752,979
|
|
G |
Eid3 |
EP300 interacting inhibitor of differentiation 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of EID3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:20,860,073...20,861,395
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
ISO |
4-hydroxy-2-nonenal results in increased phosphorylation of EIF2A protein |
CTD |
PMID:19041636 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation |
ISO |
4-hydroxy-2-nonenal results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:19041636 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases phosphorylation |
EXP |
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:24291486 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of EIF4E mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4e2 |
eukaryotic translation initiation factor 4E family member 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of EIF4E2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:87,886,126...87,914,470
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases phosphorylation |
EXP |
4-hydroxy-2-nonenal results in increased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:9890986 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of EIF5A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ELK1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Eloc |
elongin C |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ELOC mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:2,661,527...2,677,893
Ensembl chr 5:2,661,724...2,677,890
|
|
G |
Elp1 |
elongator acetyltransferase complex subunit 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ELP1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:71,453,338...71,505,833
Ensembl chr 5:71,456,310...71,505,762
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EME1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
|
|
G |
Eno1 |
enolase 1 |
affects binding |
ISO |
4-hydroxy-2-nonenal binds to ENO1 protein |
CTD |
PMID:19374891 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of EPHX1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EPS15 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:124,045,865...124,146,221
Ensembl chr 5:124,045,926...124,146,221
|
|
G |
Eps8 |
EGFR pathway substrate 8, signaling adaptor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EPS8 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Epsti1 |
epithelial stromal interaction 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EPSTI1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ERBB2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ERBB4 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ERCC1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ERCC2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ERCC5 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ERCC6L mRNA |
CTD |
PMID:19191707 |
|
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ERN1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ESPL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ETS1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ETS2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Etv3 |
ETS variant transcription factor 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ETV3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ETV6 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
|
|
G |
Ezr |
ezrin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of EZR mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F10 |
coagulation factor X |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of F10 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of F2R mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of F3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fancd2 |
FA complementation group D2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FANCD2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FASTK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fbxl17 |
F-box and leucine-rich repeat protein 17 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FBXL17 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:102,780,573...103,206,978
Ensembl chr 9:102,782,440...103,208,950
|
|
G |
Fbxl20 |
F-box and leucine-rich repeat protein 20 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FBXL20 mRNA 4-hydroxy-2-nonenal results in increased expression of FBXL20 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:83,080,568...83,143,680
Ensembl chr10:83,086,551...83,144,162
|
|
G |
Fbxo15 |
F-box protein 15 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FBXO15 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo22 |
F-box protein 22 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FBXO22 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fbxo30 |
F-box protein 30 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FBXO30 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
|
|
G |
Fbxo31 |
F-box protein 31 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FBXO31 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:49,624,813...49,656,052
Ensembl chr19:49,627,686...49,656,010
|
|
G |
Fbxo39 |
F-box protein 39 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FBXO39 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FBXO5 mRNA 4-hydroxy-2-nonenal results in increased expression of FBXO5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fcgr1a |
Fc gamma receptor 1A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FCGR1 mRNA; 4-hydroxy-2-nonenal results in decreased expression of FCGR1A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FCGR2B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FECH mRNA |
CTD |
PMID:12419474 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fem1c |
fem-1 homolog C |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FEM1C mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:39,232,900...39,258,692
Ensembl chr18:39,232,900...39,258,692
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
increases expression decreases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FEN1 mRNA 4-hydroxy-2-nonenal results in decreased expression of FEN1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FGFR1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
increases expression decreases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FGR mRNA 4-hydroxy-2-nonenal results in decreased expression of FGR mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
|
|
G |
Fkbp14 |
FKBP prolyl isomerase 14 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FKBP14 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:83,705,531...83,721,515
Ensembl chr 4:83,705,652...83,721,528
|
|
G |
Fkbpl |
FKBP prolyl isomerase like |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of FKBPL mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:4,099,845...4,101,315
Ensembl chr20:4,099,806...4,101,368
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal results in decreased expression of FOS mRNA 4-hydroxy-2-nonenal results in decreased expression of FOS protein resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of FOS protein] 4-hydroxy-2-nonenal promotes the reaction [FOS protein binds to GGT1 promoter] |
CTD |
PMID:12419474 PMID:16195535 PMID:16322078 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
4-hydroxy-2-nonenal promotes the reaction [FOSB protein binds to GGT1 promoter] |
CTD |
PMID:16195535 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions |
EXP |
4-hydroxy-2-nonenal promotes the reaction [FOSL1 protein binds to GGT1 promoter]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]] |
CTD |
PMID:9890986 PMID:16195535 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
multiple interactions |
EXP |
4-hydroxy-2-nonenal promotes the reaction [FOSL2 protein binds to GGT1 promoter] |
CTD |
PMID:16195535 |
|
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FOXM1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
FOXO3 protein inhibits the reaction [SRT1720 inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal]] |
CTD |
PMID:24633890 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp1 |
forkhead box P1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FOXP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Fpr3 |
formyl peptide receptor 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FPR3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:58,884,427...58,893,472
Ensembl chr 1:58,845,118...58,893,467
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of FUBP1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Fxn |
frataxin |
multiple interactions |
ISO |
4-hydroxy-2-nonenal affects the reaction [Ethanol affects the expression of FXN protein] |
CTD |
PMID:33017621 |
|
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of G6PDX mRNA |
CTD |
PMID:19191707 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabarapl1 |
GABA type A receptor associated protein like 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GABARAPL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal results in increased expression of GADD45A mRNA Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GADD45A mRNA] |
CTD |
PMID:19191707 PMID:24291486 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gak |
cyclin G associated kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GAK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
multiple interactions |
ISO |
[Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to GAPDH protein]] which results in decreased activity of GAPDH protein; [Hydroxyurea results in increased abundance of Free Radicals] promotes the reaction [4-hydroxy-2-nonenal binds to GAPDH protein]; Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to GAPDH protein] |
CTD |
PMID:20889679 PMID:23696560 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gata3 |
GATA binding protein 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GATA3 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gatad2b |
GATA zinc finger domain containing 2B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GATAD2B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:175,748,594...175,829,837
Ensembl chr 2:175,749,433...175,825,542
|
|
G |
Gatb |
glutamyl-tRNA amidotransferase subunit B |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GATB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:170,930,547...171,017,133
Ensembl chr 2:170,930,542...171,016,695
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GBP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gbp4 |
guanylate binding protein 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GBP3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
|
|
G |
Gbp5 |
guanylate binding protein 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GBP5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:231,237,748...231,257,071
Ensembl chr 2:231,237,748...231,257,061
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal results in increased expression of GCLC mRNA 4-hydroxy-2-nonenal results in increased expression of GCLC protein NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GCLC mRNA] |
CTD |
PMID:19191707 PMID:24291486 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GCLM mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gen1 |
GEN1 Holliday junction 5' flap endonuclease |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GEN1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
|
|
G |
Ggnbp1 |
gametogenetin binding protein 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GGNBP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:5,109,849...5,116,185
Ensembl chr20:5,099,311...5,116,183
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GGT1 mRNA]; 4-hydroxy-2-nonenal promotes the reaction [FOS protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [FOSB protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [FOSL1 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [FOSL2 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [JUN protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [JUNB protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [NFE2L1 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [NFE2L2 protein binds to GGT1 promoter]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GGT1 mRNA] |
CTD |
PMID:16195535 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gna13 |
G protein subunit alpha 13 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GNA13 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:94,337,939...94,370,774
Ensembl chr10:94,337,725...94,370,774
|
|
G |
Gnaq |
G protein subunit alpha q |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GNAQ mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
|
|
G |
Gnas |
GNAS complex locus |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GNAS mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnat3 |
G protein subunit alpha transducin 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GNAT3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:17,162,500...17,212,283
Ensembl chr 4:17,162,490...17,212,283
|
|
G |
Gnb1 |
G protein subunit beta 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GNB1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
|
|
G |
Gnb2 |
G protein subunit beta 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GNB2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
multiple interactions |
ISO |
Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to GOT2 protein] |
CTD |
PMID:20889679 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpr183 |
G protein-coupled receptor 183 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GPR183 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases abundance |
ISO |
GPX1 gene mutant form results in increased abundance of 4-hydroxy-2-nonenal |
CTD |
PMID:24296279 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GPX2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases expression decreases phosphorylation |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GSK3B mRNA 4-hydroxy-2-nonenal results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:12419474 PMID:24825450 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GSN mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GSR mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GSS mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases response to substance increases expression affects metabolic processing multiple interactions |
ISO EXP |
GSTA1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of GSTA1 mRNA GSTA1 protein affects the metabolism of 4-hydroxy-2-nonenal analog [GSTA1 protein binds to GSTA3 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog |
CTD |
PMID:9799558 PMID:11256969 PMID:15829614 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
multiple interactions |
EXP |
[GSTA1 protein binds to GSTA3 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog |
CTD |
PMID:11256969 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
multiple interactions affects metabolic processing increases expression |
ISO EXP |
GSTA4 protein binds to and affects the metabolism of 4-hydroxy-2-nonenal GSTA4 protein affects the metabolism of 4-hydroxy-2-nonenal; GSTA4 protein affects the metabolism of 4-hydroxy-2-nonenal analog 4-hydroxy-2-nonenal results in increased expression of GSTA4 mRNA; 4-hydroxy-2-nonenal results in increased expression of GSTA4 protein |
CTD |
PMID:2619714 PMID:7878679 PMID:8142470 PMID:8203886 PMID:9461507 PMID:9799558 PMID:10514034 PMID:11162605 PMID:11256969 PMID:11302754 PMID:11488593 PMID:12600725 PMID:15829614 PMID:16005854 More...
|
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of GSTA1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions affects metabolic processing |
ISO EXP |
[GSTM1 protein co-treated with 4-hydroxy-2-nonenal] results in decreased abundance of Glutathione; [GSTM1 protein co-treated with ABCC1 protein] results in increased susceptibility to 4-hydroxy-2-nonenal GSTM1 protein affects the metabolism of 4-hydroxy-2-nonenal analog [GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog |
CTD |
PMID:11256969 PMID:21925487 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
decreases response to substance multiple interactions affects metabolic processing |
ISO EXP |
GSTM2 protein results in decreased susceptibility to 4-hydroxy-2-nonenal [GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog GSTM2 protein affects the metabolism of 4-hydroxy-2-nonenal analog |
CTD |
PMID:11256969 PMID:15829614 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions decreases response to substance increases expression affects binding decreases expression |
ISO EXP |
4-hydroxy-2-nonenal binds to and results in decreased activity of GSTP1 protein GSTP1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of GSTP1 protein 4-hydroxy-2-nonenal analog binds to GSTP1 4-hydroxy-2-nonenal results in decreased expression of GSTP1 protein Glutathione inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of GSTP1 protein] 4-hydroxy-2-nonenal results in increased expression of GSTP1 mRNA |
CTD |
PMID:9463521 PMID:11600134 PMID:15829614 PMID:18232660 PMID:19191707 PMID:20570720 More...
|
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtf2b |
general transcription factor IIB |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of GTF2B mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases expression increases phosphorylation |
ISO |
POLH protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; POLK protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; POLL protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; REV1 protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; REV3L protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] 4-hydroxy-2-nonenal results in increased expression of H2AX protein [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in increased expression of H2AX protein |
CTD |
PMID:22331492 PMID:34503147 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
decreases activity |
ISO |
4-hydroxy-2-nonenal results in decreased activity of H6PD protein |
CTD |
PMID:20211231 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Haspin |
histone H3 associated protein kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HASPIN mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HBEGF mRNA |
CTD |
PMID:12419474 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HBP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HCK mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hdc |
histidine decarboxylase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HDC mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Hells |
helicase, lymphoid specific |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HELLS mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Herc3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HERC3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:87,952,202...88,042,492
Ensembl chr 4:87,952,274...88,042,488
|
|
G |
Herc6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HERC5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
|
|
G |
Hgf |
hepatocyte growth factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HGF mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hint1 |
histidine triad nucleotide binding protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HINT1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
|
|
G |
Hivep2 |
HIVEP zinc finger 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HIVEP2 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 1:8,358,205...8,555,993
Ensembl chr 1:8,359,289...8,555,993
|
|
G |
Hivep3 |
HIVEP zinc finger 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HIVEP3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795
|
|
G |
Hlx |
H2.0-like homeobox |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HLX mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:96,280,335...96,285,750
Ensembl chr13:96,280,339...96,285,750
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HMGA1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HMGA2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal analog results in increased expression of HMOX1; 4-hydroxy-2-nonenal results in increased expression of HMOX1; 4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA; 4-hydroxy-2-nonenal results in increased expression of HMOX1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; methyl-beta-cyclodextrin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; wortmannin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; wortmannin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein] 4-phenylbutylamine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; wortmannin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein] |
CTD |
PMID:18232660 PMID:19191707 PMID:20638469 PMID:23845594 PMID:24291486 PMID:24423726 PMID:30849339 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HNF4A mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HPRT1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HSD17B11 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
affects binding |
EXP ISO |
4-hydroxy-2-nonenal binds to HSP90AA1 protein 4-hydroxy-2-nonenal analog binds to HSP90AA1 |
CTD |
PMID:18232660 PMID:21749116 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
affects binding |
EXP |
4-hydroxy-2-nonenal binds to HSP90AB1 protein |
CTD |
PMID:21749116 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
affects binding |
ISO |
4-hydroxy-2-nonenal analog binds to HSPA1A |
CTD |
PMID:18232660 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HSPA1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
affects binding |
ISO |
4-hydroxy-2-nonenal analog binds to HSPA1L |
CTD |
PMID:18232660 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HSPA2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa4l |
heat shock protein family A (Hsp70) member 4 like |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HSPA4L mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
affects binding multiple interactions increases expression |
ISO EXP |
4-hydroxy-2-nonenal analog binds to HSPA5 Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA] 4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA; 4-hydroxy-2-nonenal results in increased expression of HSPA5 protein |
CTD |
PMID:18232660 PMID:24291486 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
affects binding |
ISO |
4-hydroxy-2-nonenal analog binds to HSPA9 |
CTD |
PMID:18232660 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
affects binding |
ISO |
4-hydroxy-2-nonenal analog binds to HSPD1 |
CTD |
PMID:18232660 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HSPH1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of HTATIP2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Hus1 |
HUS1 checkpoint clamp component |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of HUS1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:83,688,702...83,703,466
Ensembl chr14:83,688,708...83,703,442
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of ICAM1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ID1 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of IDH1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Ier3 |
immediate early response 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IER3 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IFI44L mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IFIH1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IFIT2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IFIT3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IFITM2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein] |
CTD |
PMID:19627980 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein; [Trichloroethylene co-treated with 4-hydroxy-2-nonenal analog] results in increased expression of IFNG protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein] |
CTD |
PMID:18267128 PMID:33007382 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of IGF1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IGF1R mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of IKBKE mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IKZF1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il10 |
interleukin 10 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL10 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of IL10RA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il12rb1 |
interleukin 12 receptor subunit beta 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL12RB1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL13RA1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
|
|
G |
Il17a |
interleukin 17A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL17A mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL18 mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il18rap |
interleukin 18 receptor accessory protein |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL18RAP mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL1A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL1RL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL1RN mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Trichloroethylene co-treated with 4-hydroxy-2-nonenal analog] results in increased expression of IL2 protein |
CTD |
PMID:18267128 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il27 |
interleukin 27 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL27 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
|
|
G |
Il3 |
interleukin 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il36a |
interleukin 36, alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL36A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:6,996,851...7,001,400
Ensembl chr 3:6,996,851...7,001,400
|
|
G |
Il4r |
interleukin 4 receptor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL4RA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL6 mRNA [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein] |
CTD |
PMID:19191707 PMID:33007382 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL6R mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL6ST mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Il7r |
interleukin 7 receptor |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL7R mRNA 4-hydroxy-2-nonenal results in increased expression of IL7R mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Il9 |
interleukin 9 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IL9 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895
|
|
G |
Impact |
impact RWD domain protein |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IMPACT mRNA 4-hydroxy-2-nonenal results in increased expression of IMPACT mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:4,108,872...4,147,571
Ensembl chr18:4,108,853...4,147,569
|
|
G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of INPPL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:156,183,043...156,197,500
Ensembl chr 1:156,183,059...156,197,500
|
|
G |
Insig2 |
insulin induced gene 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of INSIG2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IRAK3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of IRF3 protein]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRF3 protein] |
CTD |
PMID:19627980 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IRF7 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irf8 |
interferon regulatory factor 8 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IRF8 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
|
|
G |
Irgm |
immunity-related GTPase M |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IRGM mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ISG15 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ISG20 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Itga5 |
integrin subunit alpha 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ITGA5 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
|
|
G |
Itga6 |
integrin subunit alpha 6 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ITGA6 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itga7 |
integrin subunit alpha 7 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ITGA7 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
|
|
G |
Itgal |
integrin subunit alpha L |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ITGAL mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Itgam |
integrin subunit alpha M |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ITGAM mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb6 |
integrin subunit beta 6 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ITGB6 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
|
|
G |
Itsn1 |
intersectin 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of ITSN1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
|
|
G |
Jak2 |
Janus kinase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of JAK2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jdp2 |
Jun dimerization protein 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of JDP2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions increases phosphorylation affects response to substance |
ISO EXP |
4-hydroxy-2-nonenal results in decreased expression of JUN mRNA 4-hydroxy-2-nonenal promotes the reaction [JUN protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]; 4-hydroxy-2-nonenal results in increased expression of and results in increased localization of JUN protein; 4-hydroxy-2-nonenal results in increased expression of and results in increased phosphorylation of JUN protein; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein]; Quercetin inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein] JUN protein affects the susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUN protein]; 4-hydroxy-2-nonenal results in increased expression of and results in increased phosphorylation of JUN protein; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUN protein]]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUN protein]]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of and results in increased phosphorylation of JUN protein] |
CTD |
PMID:9890986 PMID:11488593 PMID:12419474 PMID:16195535 PMID:16322078 PMID:16337876 PMID:17263905 More...
|
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
4-hydroxy-2-nonenal promotes the reaction [JUNB protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]] |
CTD |
PMID:9890986 PMID:16195535 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal results in decreased expression of JUND mRNA 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]] |
CTD |
PMID:9890986 PMID:12419474 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kat8 |
lysine acetyltransferase 8 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of KAT8 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:182,524,355...182,536,638
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Kdm6b |
lysine demethylase 6B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of KDM6B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
|
|
G |
Kif11 |
kinesin family member 11 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of KIF11 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif20b |
kinesin family member 20B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of KIF20B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
|
|
G |
Kitlg |
KIT ligand |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of KITL mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf7 |
KLF transcription factor 7 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of KLF7 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
|
|
G |
Klhl6 |
kelch-like family member 6 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of KLHL6 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:80,970,917...81,010,593
Ensembl chr11:80,970,917...81,009,677
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of KPNA2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
increases expression multiple interactions |
ISO |
4-hydroxy-2-nonenal results in increased expression of LAMP1 mRNA; 4-hydroxy-2-nonenal results in increased expression of LAMP1 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of LAMP1 protein]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of LAMP1 protein] |
CTD |
PMID:35550146 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Lat |
linker for activation of T cells |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LAT mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LCAT mRNA |
CTD |
PMID:12419474 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Lck |
LCK proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LCK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:141,888,318...141,916,945
Ensembl chr 5:141,888,326...141,903,794
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LIF mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lipa |
lipase A, lysosomal acid type |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of LIPA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
|
|
G |
Lipg |
lipase G, endothelial type |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LIPG mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of LPAR1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
|
|
G |
Lpin1 |
lipin 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of LPIN1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lrrc59 |
leucine rich repeat containing 59 |
affects binding |
ISO |
LRRC59 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
|
|
G |
Lrrfip2 |
LRR binding FLII interacting protein 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of LRRFIP2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:111,091,453...111,193,947
Ensembl chr 8:111,091,503...111,193,255
|
|
G |
Ltb |
lymphotoxin beta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LTB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LY6E mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Ly96 |
lymphocyte antigen 96 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of LY96 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
|
|
G |
Lyn |
LYN proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of LYN mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
|
|
G |
Maf1 |
MAF1 homolog, negative regulator of RNA polymerase III |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MAF1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:108,075,173...108,078,252
Ensembl chr 7:108,075,189...108,078,249
|
|
G |
Mafb |
MAF bZIP transcription factor B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MAFB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MAFG mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MAP2K5 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
|
|
G |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MAP3K20 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:57,130,539...57,289,943
Ensembl chr 3:57,130,551...57,289,626
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases activity multiple interactions increases phosphorylation |
ISO EXP |
4-hydroxy-2-nonenal results in decreased activity of MAPK1 protein 4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; 4-hydroxy-2-nonenal results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]; 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK1 protein; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK1 protein 4-hydroxy-2-nonenal results in increased activity of and results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:16322078 PMID:17263905 PMID:23845594 PMID:24291486 PMID:24423726 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions increases expression |
ISO |
4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein; Acetylcysteine inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; Hydrogen Peroxide promotes the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein] 4-hydroxy-2-nonenal results in increased expression of MAPK14 mRNA 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein] |
CTD |
PMID:12684028 PMID:16322078 PMID:19191707 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases activity multiple interactions increases phosphorylation |
ISO EXP |
4-hydroxy-2-nonenal results in decreased activity of MAPK3 protein 4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; 4-hydroxy-2-nonenal results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]; 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK3 protein; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK3 protein 4-hydroxy-2-nonenal results in increased activity of and results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:16322078 PMID:17263905 PMID:23845594 PMID:24291486 PMID:24423726 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases activity increases phosphorylation affects response to substance multiple interactions |
ISO |
4-hydroxy-2-nonenal results in increased activity of MAPK8 protein 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK8 protein MAPK8 protein affects the susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein; GSTA4 protein inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of MAPK8 protein]; Resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein] 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein; Hydrogen Peroxide promotes the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein] |
CTD |
PMID:11488593 PMID:12684028 PMID:15064094 PMID:16322078 PMID:17263905 PMID:24825450 More...
|
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
4-hydroxy-2-nonenal results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:24825450 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Marcksl1 |
MARCKS-like 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MARCKSL1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
|
|
G |
Mark3 |
microtubule affinity regulating kinase 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MARK3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MCM4 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MCM6 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of METAP1D mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:56,279,471...56,354,518
Ensembl chr 3:56,279,493...56,351,981
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit |
multiple interactions |
ISO |
METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of 4-hydroxy-2-nonenal] |
CTD |
PMID:34648132 |
|
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Mitf |
melanocyte inducing transcription factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MITF mRNA |
CTD |
PMID:23489423 |
|
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MKI67 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mknk1 |
MAPK interacting serine/threonine kinase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MKNK1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
|
|
G |
Mlh1 |
mutL homolog 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MLH1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases activity increases expression |
ISO |
4-hydroxy-2-nonenal results in increased activity of MMP1 protein 4-hydroxy-2-nonenal results in increased expression of MMP1 mRNA |
CTD |
PMID:14672615 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases activity increases expression multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal results in increased activity of MMP2 protein 4-hydroxy-2-nonenal results in increased expression of MMP2 mRNA 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2]; 4-hydroxy-2-nonenal results in increased expression of and results in increased secretion of and results in increased activity of MMP2 protein; AKT1 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2 protein] |
CTD |
PMID:14672615 PMID:18805481 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression increases activity multiple interactions increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MMP9 mRNA 4-hydroxy-2-nonenal results in increased activity of MMP9 protein ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]; alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]; MK-886 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]; U 75302 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein] 4-hydroxy-2-nonenal results in increased expression of MMP9 mRNA; 4-hydroxy-2-nonenal results in increased expression of MMP9 protein |
CTD |
PMID:19191707 PMID:19837106 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mnda |
myeloid cell nuclear differentiation antigen |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of IFI16 mRNA; 4-hydroxy-2-nonenal results in decreased expression of IFI204 mRNA 4-hydroxy-2-nonenal results in decreased expression of MNDA mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
|
|
G |
Mocos |
molybdenum cofactor sulfurase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MOCOS mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:15,931,659...15,977,415
Ensembl chr18:15,931,654...15,977,187
|
|
G |
Mov10 |
Mov10 RNA helicase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MOV10 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:192,292,041...192,315,142
Ensembl chr 2:192,293,470...192,315,083
|
|
G |
Ms4a6a |
membrane spanning 4-domains A6A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MS4A6C mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
|
|
G |
Msh5 |
mutS homolog 5 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MSH5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MT1 mRNA |
CTD |
PMID:20979157 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MT2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfs |
methenyltetrahydrofolate synthetase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MTHFS mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:89,729,498...89,801,998
Ensembl chr 8:89,729,508...89,799,089
|
|
G |
Mtmr10 |
myotubularin related protein 10 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MTMR10 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:117,859,355...117,910,839
Ensembl chr 1:117,859,267...117,910,849
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MTOR mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtss1 |
MTSS I-BAR domain containing 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MTSS1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
|
|
G |
Mutyh |
mutY DNA glycosylase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of MUTYH mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:130,274,034...130,286,149
Ensembl chr 5:130,274,122...130,286,146
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MX1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Mx2 |
MX dynamin like GTPase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MX2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342
|
|
G |
Mxd1 |
max dimerization protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MXD1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MYBL2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MYC mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mylk |
myosin light chain kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of MYLK mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Nab2 |
Ngfi-A binding protein 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NAB2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:63,497,589...63,504,105
Ensembl chr 7:63,497,589...63,503,989
|
|
G |
Napb |
NSF attachment protein beta |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NAPB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:136,132,248...136,179,280
Ensembl chr 3:136,133,428...136,179,345
|
|
G |
Nbn |
nibrin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NBN mRNA |
CTD |
PMID:12419474 PMID:19191707 |
|
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
|
|
G |
Nck1 |
NCK adaptor protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NCK1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:101,018,610...101,079,237
Ensembl chr 8:101,018,702...101,079,300
|
|
G |
Ndc80 |
NDC80 kinetochore complex component |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NDC80 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
|
|
G |
Nectin1 |
nectin cell adhesion molecule 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NECTIN1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
|
|
G |
Neil3 |
nei-like DNA glycosylase 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NEIL3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:38,359,305...38,418,528
Ensembl chr16:38,359,371...38,418,527
|
|
G |
Nek2 |
NIMA-related kinase 2 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NEK2 mRNA 4-hydroxy-2-nonenal results in increased expression of NEK2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
|
|
G |
Nek3 |
NIMA-related kinase 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NEK3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:69,867,020...69,892,477
Ensembl chr16:69,867,047...69,892,508
|
|
G |
Nek6 |
NIMA-related kinase 6 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NEK6 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
|
|
G |
Neo1 |
neogenin 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NEO1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
|
|
G |
Neu1 |
neuraminidase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NEU1 mRNA |
CTD |
PMID:35550146 |
|
NCBI chr20:3,897,480...3,901,745
Ensembl chr20:3,897,480...3,901,745
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NF2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
|
|
G |
Nfam1 |
NFAT activating protein with ITAM motif 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NFAM1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:114,139,318...114,175,395
Ensembl chr 7:114,139,345...114,175,442
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NFATC1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfe2l1 |
NFE2 like bZIP transcription factor 1 |
decreases expression multiple interactions increases expression |
ISO EXP |
4-hydroxy-2-nonenal results in decreased expression of NFE2L1 mRNA 4-hydroxy-2-nonenal promotes the reaction [NFE2L1 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased expression of and results in increased localization of NFE2L1 protein 4-hydroxy-2-nonenal results in increased expression of NFE2L1 protein |
CTD |
PMID:12419474 PMID:16195535 |
|
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases activity multiple interactions affects response to substance affects localization increases expression |
ISO EXP |
4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein AKR7A2 protein affects the reaction [NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal] 4-hydroxy-2-nonenal affects the localization of NFE2L2 protein 4-hydroxy-2-nonenal affects the localization of and results in increased activity of NFE2L2 protein; [GSTA4 protein mutant form results in decreased glutathionylation of 4-hydroxy-2-nonenal] which results in increased activity of NFE2L2 protein; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein] 4-hydroxy-2-nonenal results in increased expression of NFE2L2 protein 4-hydroxy-2-nonenal promotes the reaction [NFE2L2 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased expression of and results in increased localization of NFE2L2 protein; NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GCLC mRNA]; NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA] |
CTD |
PMID:16195535 PMID:16322078 PMID:19880816 PMID:24291486 PMID:24423726 PMID:24633890 PMID:29108775 PMID:30849339 More...
|
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfic |
nuclear factor I/C |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NFIC mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
|
|
G |
Nfix |
nuclear factor I X |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NFIX mRNA |
CTD |
PMID:12419474 |
|
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression multiple interactions |
ISO EXP |
4-hydroxy-2-nonenal results in decreased expression of NFKB1 mRNA 4-hydroxy-2-nonenal results in decreased activity of [NFKB1 protein binds to NFKB1 protein]; 4-hydroxy-2-nonenal results in decreased activity of [RELA protein binds to NFKB1 protein] |
CTD |
PMID:11146106 PMID:12419474 PMID:19191707 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases expression |
ISO |
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] 4-hydroxy-2-nonenal results in increased expression of NFKBIA mRNA |
CTD |
PMID:19191707 PMID:19627980 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbie |
NFKB inhibitor epsilon |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NFKBIE mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NFKBIZ mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Nfrkb |
nuclear factor related to kappa B binding protein |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NFRKB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 8:29,831,802...29,863,360
Ensembl chr 8:29,831,812...29,863,359
|
|
G |
Nfx1 |
nuclear transcription factor, X-box binding 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NFX1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 5:56,104,945...56,162,912
Ensembl chr 5:56,105,234...56,162,912
|
|
G |
Nkiras1 |
NFKB inhibitor interacting Ras-like 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NKIRAS1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:7,493,531...7,503,758
Ensembl chr15:7,493,531...7,503,854
|
|
G |
Nlrc4 |
NLR family, CARD domain containing 4 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NLRC4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:20,991,785...21,018,254
Ensembl chr 6:20,995,266...21,018,248
|
|
G |
Nlrp10 |
NLR family, pyrin domain containing 10 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NLRP10 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:162,922,806...162,930,363
Ensembl chr 1:162,922,806...162,930,363
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NLRP3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nmb |
neuromedin B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NMB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NME2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NOS2 protein |
CTD |
PMID:20940037 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NOTCH1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NQO1 mRNA 4-hydroxy-2-nonenal results in increased expression of NQO1 mRNA; 4-hydroxy-2-nonenal results in increased expression of NQO1 protein |
CTD |
PMID:24423726 PMID:29108775 PMID:30849339 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NR1D1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NR1D2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NR1I3 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NR2F6 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:18,046,012...18,053,914
Ensembl chr16:18,046,013...18,053,459
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NR3C1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NR4A1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nrp1 |
neuropilin 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NRP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
|
|
G |
Nsl1 |
NSL1 component of MIS12 kinetochore complex |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NSL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054
|
|
G |
Nuf2 |
NUF2 component of NDC80 kinetochore complex |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NUF2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
|
|
G |
Nufip1 |
nuclear FMR1 interacting protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NUFIP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:51,429,518...51,460,308
Ensembl chr15:51,429,549...51,460,310
|
|
G |
Nup210 |
nucleoporin 210 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NUP210 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
|
|
G |
Nup85 |
nucleoporin 85 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of NUP85 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:100,806,482...100,825,029
Ensembl chr10:100,806,437...100,825,043
|
|
G |
Nusap1 |
nucleolar and spindle associated protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of NUSAP1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
|
|
G |
Oas3 |
2'-5'-oligoadenylate synthetase 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of OAS3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
|
|
G |
Olr1271 |
olfactory receptor 1271 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of OR8D1 mRNA; 4-hydroxy-2-nonenal results in increased expression of OR8D1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:39,127,409...39,131,889
Ensembl chr 8:39,127,352...39,131,900
|
|
G |
Osm |
oncostatin M |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of OSM mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
|
|
G |
Otub1 |
OTU deubiquitinase, ubiquitin aldehyde binding 1 |
multiple interactions |
ISO |
[[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of 4-hydroxy-2-nonenal |
CTD |
PMID:35234341 |
|
NCBI chr 1:204,387,215...204,395,495
Ensembl chr 1:204,387,215...204,395,483
|
|
G |
P2rx5 |
purinergic receptor P2X 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of P2RX5 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of P2RY2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
affects metabolic processing |
EXP |
4-hydroxy-2-nonenal affects the metabolism of P4HB protein |
CTD |
PMID:16097806 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Pa2g4 |
proliferation-associated 2G4 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PA2G4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
|
|
G |
Paip1 |
poly(A) binding protein interacting protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PAIP1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:51,523,190...51,550,241
Ensembl chr 2:51,522,921...51,550,241
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases degradation |
ISO |
4-hydroxy-2-nonenal results in increased degradation of PARP1 protein |
CTD |
PMID:11488593 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp12 |
poly (ADP-ribose) polymerase family, member 12 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PARP12 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
|
|
G |
Pbk |
PDZ binding kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PBK mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
|
|
G |
Pcgf5 |
polycomb group ring finger 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PCGF5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:234,063,854...234,180,022
Ensembl chr 1:234,063,892...234,175,315
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PCNA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PCSK2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
|
|
G |
Pcyox1 |
prenylcysteine oxidase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PCYOX1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:118,832,114...118,842,951
Ensembl chr 4:118,830,638...118,842,951
|
|
G |
Pdcd4 |
programmed cell death 4 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PDCD4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PDGFB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
affects binding |
ISO |
4-hydroxy-2-nonenal analog binds to PDIA3 |
CTD |
PMID:18232660 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdss1 |
decaprenyl diphosphate synthase subunit 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PDSS1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:85,059,953...85,098,739
Ensembl chr17:85,060,106...85,098,730
|
|
G |
Pdyn |
prodynorphin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PDYN mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Penk |
proenkephalin |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PENK mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Per1 |
period circadian regulator 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PER1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Pex7 |
peroxisomal biogenesis factor 7 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PEX7 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:14,582,698...14,646,686
Ensembl chr 1:14,582,699...14,646,748
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PGD mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pglyrp3 |
peptidoglycan recognition protein 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PGLYRP3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:177,479,693...177,490,769
Ensembl chr 2:177,477,407...177,490,736 Ensembl chr 2:177,477,407...177,490,736
|
|
G |
Pgm2l1 |
phosphoglucomutase 2-like 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PGM2L1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:154,571,410...154,620,901
Ensembl chr 1:154,571,766...154,620,902
|
|
G |
Pgs1 |
phosphatidylglycerophosphate synthase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PGS1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:103,214,635...103,250,254
Ensembl chr10:103,214,646...103,250,254
|
|
G |
Phb1 |
prohibitin 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PHB1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Phf11 |
PHD finger protein 11 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PHF11 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
|
|
G |
Phf21a |
PHD finger protein 21A |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PHF21A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
affects binding |
ISO |
PHGDH protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PHLDA1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PIK3CB mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PIK3CD mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
|
|
G |
Pik3r2 |
phosphoinositide-3-kinase regulatory subunit 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PIK3R2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
|
|
G |
Pilra |
paired immunoglobin-like type 2 receptor alpha |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PILRA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr12:17,787,169...17,798,149
Ensembl chr12:17,787,127...17,798,094
|
|
G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
affects binding increases response to substance |
ISO |
4-hydroxy-2-nonenal binds to PIN1 protein PIN1 protein results in increased susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:23231502 |
|
NCBI chr 8:19,189,408...19,200,785
Ensembl chr 8:19,189,373...19,200,785
|
|
G |
Pkm |
pyruvate kinase M1/2 |
affects binding multiple interactions |
ISO |
4-hydroxy-2-nonenal analog binds to PKM protein 4-hydroxy-2-nonenal binds to and results in decreased activity of PKM protein; 4-hydroxy-2-nonenal promotes the reaction [PKM protein binds to PKM protein] |
CTD |
PMID:27978618 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PLA2G7 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
|
|
G |
Plagl2 |
PLAG1 like zinc finger 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PLAGL2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:141,695,322...141,708,516
Ensembl chr 3:141,695,322...141,708,503
|
|
G |
Pld2 |
phospholipase D2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PLD2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Plekhm1 |
pleckstrin homology and RUN domain containing M1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PLEKHM1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:88,313,837...88,366,182
Ensembl chr10:88,314,651...88,362,412
|
|
G |
Plekho1 |
pleckstrin homology domain containing O1 |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PLEKHO1 mRNA 4-hydroxy-2-nonenal results in increased expression of PLEKHO1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
|
|
G |
Plk1 |
polo-like kinase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PLK1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PLK2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Polb |
DNA polymerase beta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of POLB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of POLD1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
|
|
G |
Pole |
DNA polymerase epsilon, catalytic subunit |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of POLE mRNA |
CTD |
PMID:19191707 |
|
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939
|
|
G |
Polh |
DNA polymerase eta |
multiple interactions affects response to substance |
ISO |
POLH protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] POLH protein affects the susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:22331492 |
|
NCBI chr 9:14,778,355...14,813,210
Ensembl chr 9:14,777,888...14,812,723
|
|
G |
Polk |
DNA polymerase kappa |
multiple interactions |
ISO |
POLK protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] |
CTD |
PMID:22331492 |
|
NCBI chr 2:27,822,228...27,882,331
Ensembl chr 2:27,822,679...27,882,313
|
|
G |
Poll |
DNA polymerase lambda |
affects response to substance multiple interactions |
ISO |
POLL protein affects the susceptibility to 4-hydroxy-2-nonenal POLL protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] |
CTD |
PMID:22331492 |
|
NCBI chr 1:244,400,202...244,408,762
Ensembl chr 1:244,400,204...244,408,662
|
|
G |
Polq |
DNA polymerase theta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of POLQ mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions decreases activity |
ISO |
4-hydroxy-2-nonenal inhibits the reaction [PON1 protein results in increased hydrolysis of Paraoxon]; 4-hydroxy-2-nonenal inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] 4-hydroxy-2-nonenal results in decreased activity of PON1 protein |
CTD |
PMID:15375178 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pou2f2 |
POU class 2 homeobox 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of POU2F2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PPARG protein |
CTD |
PMID:27417252 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppid |
peptidylprolyl isomerase D |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PPID mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:164,727,803...164,740,168
Ensembl chr 2:164,727,779...164,740,221
|
|
G |
Ppil1 |
peptidylprolyl isomerase like 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PPIL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:7,302,292...7,322,349
Ensembl chr20:7,302,621...7,322,354
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PPP1CA mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression multiple interactions |
EXP |
4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA] |
CTD |
PMID:24291486 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ppp1r15b |
protein phosphatase 1, regulatory subunit 15B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PPP1R15B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:44,577,840...44,585,737
Ensembl chr13:44,577,932...44,585,737
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PPP3CA mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Prdm1 |
PR/SET domain 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PRDM1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
|
|
G |
Prdx1 |
peroxiredoxin 1 |
affects binding increases expression |
ISO |
4-hydroxy-2-nonenal analog binds to PRDX1 4-hydroxy-2-nonenal results in increased expression of PRDX1 mRNA |
CTD |
PMID:18232660 PMID:19191707 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PRKDC mRNA |
CTD |
PMID:12419474 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Procr |
protein C receptor |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PROCR mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
|
|
G |
Psmb10 |
proteasome 20S subunit beta 10 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PSMB10 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Psmc3ip |
PSMC3 interacting protein |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PSMC3IP mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:86,024,281...86,027,928
Ensembl chr10:86,023,950...86,027,423
|
|
G |
Psmd12 |
proteasome 26S subunit, non-ATPase 12 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PSMD12 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PTGER4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptges |
prostaglandin E synthase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PTGES mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
multiple interactions decreases response to substance |
EXP |
[PTGR1 protein co-treated with NADP] affects the reduction of 4-hydroxy-2-nonenal PTGR1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:11524419 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PTK2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PTPN1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Ptpra |
protein tyrosine phosphatase, receptor type, A |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of PTPRA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:117,650,146...117,759,744
Ensembl chr 3:117,650,183...117,759,728
|
|
G |
Pxk |
PX domain containing serine/threonine kinase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of PXK mRNA |
CTD |
PMID:19191707 |
|
NCBI chr15:16,759,857...16,828,452
Ensembl chr15:16,759,862...16,828,444
|
|
G |
Rab11a |
RAB11a, member RAS oncogene family |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RAB11A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:65,223,698...65,246,461
Ensembl chr 8:65,222,949...65,246,525
|
|
G |
Rabgef1 |
RAB guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RABGEF1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr12:26,459,190...26,503,790
Ensembl chr12:26,460,175...26,503,744
|
|
G |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RAD23A mRNA |
CTD |
PMID:19191707 |
|
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression increases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RAD51 mRNA 4-hydroxy-2-nonenal results in increased expression of RAD51 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rad54l |
RAD54 like |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RAD54L mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
|
|
G |
Raet1e |
retinoic acid early transcript 1E |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RAET1E mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:1,662,665...1,664,609
Ensembl chr 1:1,807,644...1,812,755
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RAF1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Ralbp1 |
ralA binding protein 1 |
decreases response to substance |
ISO |
RALBP1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:15950949 |
|
NCBI chr 9:105,456,425...105,493,235
Ensembl chr 9:105,456,425...105,492,707
|
|
G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RALGDS mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 3:11,839,686...11,880,059
Ensembl chr 3:11,839,416...11,880,059
|
|
G |
Ralgps1 |
Ral GEF with PH domain and SH3 binding motif 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RALGPS1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:16,433,323...16,670,276
Ensembl chr 3:16,433,742...16,669,972
|
|
G |
Rara |
retinoic acid receptor, alpha |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RARA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rarb |
retinoic acid receptor, beta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RARB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rasgef1b |
RasGEF domain family, member 1B |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RASGEF1B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741
|
|
G |
Rasgrp3 |
RAS guanyl releasing protein 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RASGRP3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578
|
|
G |
Rassf2 |
Ras association domain family member 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RASSF2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:119,244,288...119,280,462
Ensembl chr 3:119,245,821...119,280,431
|
|
G |
Rassf8 |
Ras association domain family member 8 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RASSF8 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation multiple interactions |
ISO |
4-hydroxy-2-nonenal results in decreased phosphorylation of RB1 protein [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of RB1 protein modified form |
CTD |
PMID:15607904 PMID:33007382 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbl1 |
RB transcriptional corepressor like 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RBL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
|
|
G |
Rbl2 |
RB transcriptional corepressor like 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RBL2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of REL mRNA |
CTD |
PMID:12419474 |
|
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
4-hydroxy-2-nonenal results in decreased activity of [RELA protein binds to NFKB1 protein] |
CTD |
PMID:11146106 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
multiple interactions affects response to substance |
ISO |
REV1 protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] REV1 protein affects the susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:22331492 |
|
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
|
|
G |
Rev3l |
REV3 like, DNA directed polymerase zeta catalytic subunit |
multiple interactions affects response to substance |
ISO |
REV3L protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] REV3L protein affects the susceptibility to 4-hydroxy-2-nonenal |
CTD |
PMID:22331492 |
|
NCBI chr20:43,131,841...43,290,102
Ensembl chr20:43,132,363...43,290,099
|
|
G |
Rffl |
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RFFL mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:67,740,711...67,803,669
Ensembl chr10:67,740,712...67,824,434
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RGS1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
|
|
G |
Rig1 |
RNA sensor RIG-1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RIGI mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
|
|
G |
Riok3 |
RIO kinase 3 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RIOK3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr18:3,327,776...3,353,350
Ensembl chr18:3,327,776...3,353,343
|
|
G |
Rit1 |
Ras-like without CAAX 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RIT1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:174,180,742...174,195,455
Ensembl chr 2:174,180,848...174,195,455
|
|
G |
Rnd1 |
Rho family GTPase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RND1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
|
|
G |
Rnf128 |
ring finger protein 128 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RNF128 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr X:103,183,643...103,298,431
Ensembl chr X:103,183,831...103,298,423
|
|
G |
Rnf167 |
ring finger protein 167 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RNF167 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:55,360,603...55,364,927
Ensembl chr10:55,360,543...55,364,927
|
|
G |
Rnf19b |
ring finger protein 19B |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RNF19B mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
|
|
G |
Rpp38 |
ribonuclease P/MRP subunit p38 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RPP38 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:74,914,066...74,917,742
Ensembl chr17:74,908,932...74,927,431
|
|
G |
Rps6ka2 |
ribosomal protein S6 kinase A2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RPS6KA2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:52,631,582...52,906,739
Ensembl chr 1:52,631,736...52,906,739
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation |
EXP |
4-hydroxy-2-nonenal results in increased phosphorylation of RPS6KB1 protein |
CTD |
PMID:19289642 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RSAD2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of H2-T23 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of H2-Q1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
|
|
G |
Rxra |
retinoid X receptor alpha |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of RXRA mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Rxrb |
retinoid X receptor beta |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of RXRB mRNA |
CTD |
PMID:12419474 |
|
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
|
|
G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of S1PR2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:19,503,276...19,514,169
Ensembl chr 8:19,502,627...19,523,574
|
|
G |
Samhd1 |
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 |
affects binding |
ISO |
SAMHD1 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
|
|
G |
Samsn1 |
SAM domain, SH3 domain and nuclear localization signals, 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SAMSN1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
|
|
G |
Sass6 |
SAS-6 centriolar assembly protein |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SASS6 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:204,546,660...204,578,930
Ensembl chr 2:204,546,660...204,578,927
|
|
G |
Satb1 |
SATB homeobox 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SATB1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
|
|
G |
Sbno2 |
strawberry notch homolog 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SBNO2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 7:9,605,572...9,649,529
Ensembl chr 7:9,605,627...9,649,527
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions affects binding |
ISO |
Tobacco Smoke Pollution promotes the reaction [4-hydroxy-2-nonenal binds to SCARB1 protein] |
CTD |
PMID:22442701 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Selenbp1 |
selenium binding protein 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SELENBP1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
G |
Serbp1 |
Serpine1 mRNA binding protein 1 |
affects binding |
ISO |
SERBP1 protein binds to 4-hydroxy-2-nonenal |
CTD |
PMID:20043646 |
|
NCBI chr 4:96,401,587...96,421,816
Ensembl chr 4:96,401,477...96,421,813
|
|
G |
Serpinb5 |
serpin family B member 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SERPINB5 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
|
|
G |
Serpinb9 |
serpin family B member 9 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of SERPINB9 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
|
|
G |
Serpini1 |
serpin family I member 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SERPINI1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
|
|
G |
Sesn2 |
sestrin 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SESN2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SGK1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sgo1 |
shugoshin 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SGO1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805
|
|
G |
Sgo2 |
shugoshin 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SGO2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
|
|
G |
Sgpl1 |
sphingosine-1-phosphate lyase 1 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of SGPL1 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr20:29,047,793...29,094,209
Ensembl chr20:29,047,796...29,094,084
|
|
G |
Shoc2 |
SHOC2 leucine-rich repeat scaffold protein |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SHOC2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr 1:252,958,939...253,048,820
Ensembl chr 1:252,959,723...253,047,337
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
SIRT1 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal] |
CTD |
PMID:24633890 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt3 |
sirtuin 3 |
multiple interactions |
ISO |
4-hydroxy-2-nonenal binds to and results in decreased activity of SIRT3 protein |
CTD |
PMID:21449565 |
|
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
|
|
G |
Slc25a27 |
solute carrier family 25, member 27 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SLC25A27 mRNA |
CTD |
PMID:20385226 |
|
NCBI chr 9:17,306,898...17,333,942
Ensembl chr 9:17,307,023...17,332,731
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions |
ISO |
[APC protein mutant form results in increased expression of SLC7A11 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal [[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of 4-hydroxy-2-nonenal |
CTD |
PMID:21967605 PMID:35234341 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a2 |
solute carrier family 7 member 2 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SLC7A2 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr16:51,417,478...51,470,784
Ensembl chr16:51,417,493...51,470,784
|
|
G |
Smad1 |
SMAD family member 1 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SMAD1 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
|
|
G |
Smc4 |
structural maintenance of chromosomes 4 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SMC4 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
|
|
G |
Snapc5 |
small nuclear RNA activating complex, polypeptide 5 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of SNAPC5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:64,677,204...64,680,769
Ensembl chr 8:64,677,205...64,681,964
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SOCS3 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod2 |
superoxide dismutase 2 |
affects binding increases abundance multiple interactions decreases abundance increases expression |
ISO |
4-hydroxy-2-nonenal binds to SOD2 protein SOD2 gene mutant form results in increased abundance of 4-hydroxy-2-nonenal SOD2 protein inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased abundance of 4-hydroxy-2-nonenal] SOD2 protein results in decreased abundance of 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of SOD2 mRNA |
CTD |
PMID:11507057 PMID:19191707 PMID:19374891 PMID:23199288 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sp100 |
SP100 nuclear antigen |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SP100 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
|
|
G |
Sp110 |
SP110 nuclear body protein |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SP110 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 9:86,200,503...86,225,355
Ensembl chr 9:86,200,503...86,222,670
|
|
G |
Sp2 |
Sp2 transcription factor |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SP2 mRNA |
CTD |
PMID:12419474 |
|
NCBI chr10:81,940,580...81,970,040
Ensembl chr10:81,940,587...81,970,548
|
|
G |
Spa17 |
sperm autoantigenic protein 17 |
increases expression |
ISO |
4-hydroxy-2-nonenal results in increased expression of SPA17 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr 8:37,307,432...37,318,519
Ensembl chr 8:37,307,557...37,318,639
|
|
G |
Spag5 |
sperm associated antigen 5 |
decreases expression |
ISO |
4-hydroxy-2-nonenal results in decreased expression of SPAG5 mRNA |
CTD |
PMID:19191707 |
|
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
|
| |